Document Detail


Hepatic lacI and cII mutation in transgenic (lambdaLIZ) rats treated with dimethylnitrosamine.
MedLine Citation:
PMID:  9804924     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The recent introduction of a transgenic rat in vivo mutation assay is a much needed supplement to the transgenic mouse models and offers the tools necessary for collecting target tissue specific genotoxicity data in this species. The utility of the Big Blue(R) rat for the detection of in vivo mutations was investigated by studying spontaneous and dimethylnitrosamine (DMN)-induced hepatic mutations. High molecular weight DNA isolated from Big Blue(R) rat livers typically yielded good transgene rescue efficiency of up to 5x105 plaque forming units per packaging reaction. DMN, when administered by oral gavage at dose levels of 0.2, 0.6, 2.0, and 6.0 mg kg-1 day-1, induced up to a 4.5-fold increase in mutations at the highest dose level. There was no apparent difference between the lacI vs. cII target genes of the shuttle vector in either the background or DMN-induced mutant frequencies. These results suggest that the transgenic rat model is a useful tool for studying potential genotoxicity in target organs and, with further validation, the selectable cII target could be an attractive alternative to the conventional lacI color screening method for the detection of mutations in the lambdaLIZ shuttle vector.
Authors:
B B Gollapudi; K M Jackson; W T Stott
Related Documents :
12645574 - A blocking antibody to the hyaluronan receptor for endocytosis (hare) inhibits hyaluron...
331254 - Restriction endonuclease cleavage maps of rat and mouse mitochondrial dnas.
19059164 - Quantitative real-time polymerase chain reaction (qrt-pcr) restriction fragment length ...
12536244 - Performance evaluation of the micropet r4 pet scanner for rodents.
6205574 - Indication of a certain molecular correlation between rat ige and human ige.
1562564 - Biosynthesis of androgens by the sesterterpene pathway via 23,24-dinor-4-cholen-3-one.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Mutation research     Volume:  419     ISSN:  0027-5107     ISO Abbreviation:  Mutat. Res.     Publication Date:  1998 Nov 
Date Detail:
Created Date:  1998-12-15     Completed Date:  1998-12-15     Revised Date:  2006-03-17    
Medline Journal Info:
Nlm Unique ID:  0400763     Medline TA:  Mutat Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  131-5     Citation Subset:  IM    
Copyright Information:
Copyright 1998 Elsevier Science B.V.
Affiliation:
The Dow Chemical, Health and Environmental Research Laboratory, 1803 Building, Midland, MI 48674, USA. bgollapudi@dow.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Animals, Genetically Modified*
Bacteriophage lambda / genetics
Dimethylnitrosamine / toxicity*
Lactose Factors / genetics*
Liver / ultrastructure
Mutagenicity Tests*
Mutation*
Rats
Rats, Inbred F344
Transcription Factors / genetics*
Viral Proteins
Chemical
Reg. No./Substance:
0/Transcription Factors; 0/Viral Proteins; 0/cII protein, bacteriophage lambda; 62-75-9/Dimethylnitrosamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mast cells in the neonate musk shrew brain: implications for neuroendocrine immune interactions.
Next Document:  Methylmercury-induced inhibition of regulatory volume decrease in astrocytes: characterization of os...